AVRIDI Trademark

Trademark Overview

On Monday, October 9, 2017, a trademark application was filed for AVRIDI with the United States Patent and Trademark Office. The USPTO has given the AVRIDI trademark a serial number of 87638137. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 31, 2021. This trademark is owned by Purdue Pharma L.P.. The AVRIDI trademark is filed in the Pharmaceutical Products category with the following description:

Oral analgesics
avridi

General Information

Serial Number87638137
Word MarkAVRIDI
Filing DateMonday, October 9, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 31, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 27, 2018

Trademark Statements

Goods and ServicesOral analgesics

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, October 16, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePurdue Pharma L.P.
Party Type20 - Owner at Publication
Legal Entity Type13 - Limited Partnership
AddressStamford, CT 06901
Party NamePurdue Pharma L.P.
Party Type10 - Original Applicant
Legal Entity Type13 - Limited Partnership
AddressStamford, CT 06901

Trademark Events

Event DateEvent Description
Tuesday, June 1, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, May 31, 2021ABANDONMENT - NO USE STATEMENT FILED
Tuesday, October 20, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 19, 2020EXTENSION 5 GRANTED
Thursday, October 8, 2020EXTENSION 5 FILED
Thursday, October 15, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, October 8, 2020TEAS EXTENSION RECEIVED
Wednesday, April 8, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 6, 2020EXTENSION 4 GRANTED
Monday, April 6, 2020EXTENSION 4 FILED
Monday, April 6, 2020TEAS EXTENSION RECEIVED
Friday, October 25, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 23, 2019EXTENSION 3 GRANTED
Wednesday, October 23, 2019EXTENSION 3 FILED
Wednesday, October 23, 2019TEAS EXTENSION RECEIVED
Wednesday, October 23, 2019TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, April 24, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 22, 2019EXTENSION 2 GRANTED
Monday, April 22, 2019EXTENSION 2 FILED
Monday, April 22, 2019TEAS EXTENSION RECEIVED
Saturday, September 29, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 27, 2018EXTENSION 1 GRANTED
Thursday, September 27, 2018EXTENSION 1 FILED
Thursday, September 27, 2018TEAS EXTENSION RECEIVED
Tuesday, April 24, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 27, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 27, 2018PUBLISHED FOR OPPOSITION
Wednesday, February 7, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 16, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 16, 2018ASSIGNED TO EXAMINER
Monday, October 16, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, October 12, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

avridi analgesics oral